Abstract
Epithelial ovarian cancer (EOC) is the most lethal gynecological cancer. Several approaches of active and passive immunotherapy for EOC have been studied. The aim of this systematic review was to assess the clinical efficacy of specific immunotherapy in patients with EOC. We found 4524 references in seven databases and we included ten controlled clinical trials with 2285 patients with EOC reporting five active immunotherapeutic agents and three passive immunotherapies. Meta-analysis of six studies showed that overall there was not any significant difference in overall survival and recurrence-free survival between patients undergoing specific immunotherapy and those in control group. Most of the studies we evaluated reported a positive outcome from treatment with specific immunotherapy, although this was not significant.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1193-1204 |
| Number of pages | 12 |
| Journal | Immunotherapy |
| Volume | 8 |
| Issue number | 10 |
| DOIs | |
| State | Published - Oct 2016 |
Keywords
- active immunotherapy
- clinical outcome
- immunotherapy
- meta-analysis
- ovarian cancer
- passive immunotherapy
- systematic review
- vaccines
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Oncology